Epidemiological investigation of metabolic syndrome and analysis of relevant factors in north-eastern China

Journal of International Medical Research

Volumn 38, Issue 1, 2010, Pages 150-159

  Wang, W ^a   Kong, J ^a   Sun, J ^a   Wang, C Y ^a   Chen, H Y ^a   Jiang, Y F ^a   Feng, X W ^a   He, S M ^a   Niu, J Q ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Chinese patients; Epidemiological investigation; Metabolic syndrome; Risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PREVALENCE; QUESTIONNAIRE; RANDOM SAMPLE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEX RATIO; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URBAN POPULATION; WAIST CIRCUMFERENCE;

EID: 77749283693     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800117     Document Type: Article

References (29)

1. Rutter MK, Meigs JB, Sullivan LM, et al: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 2005; 54: 3252-3257.
2. Sierra-Johnson J, Johnson BD, Allison TG, et al: Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin. Diabetes Care 2006; 29: 668-672.
3. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. WHO/NCD/NCS: Geneva, 1999; pp 31-32 (available at: http://www.staff.ncl.ac.uk/philip.home/who-dmg.pdf).
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
5. Balkau B, Charles MA, Drivsholm T, et al on behalf of The European Group for the Study of Insulin Resistance (EGIR): Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002, 2: 354-376.
6. International Diabetes Federation (IDF): The IDF consensus worldwide definition of the metabolic syndrome. Berlin: IDF, 2005 (available at: http://www.idf.org/webdata/ docs/MetSyndrome-FINAL.pdf).
7. Zimmet P, Magliano D, Matsuzawa Y, et al: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295-300.
8. Oh JY, Hong YS, Sung YA, et al: Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 2004; 27: 2027-2032.
9. Cooperative Meta-analysis Group of China Obesity Task Force: Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 2002; 23: 5-10 [in Chinese].
10. Zeng WY, Li DF, Guo WC, et al: Analysis of metabolic syndrome and relevant diseases in different populations. China Tropical Med 2006; 6: 2260-2261 [in Chinese].
11. Kannel WB, Cupples LA, Ramaswami R, et al: Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol 1991; 44: 183-190.
12. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-386.
13. Carey DG, Jenkins AB, Campbell LV, et al: Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 1996; 45: 633-638.
14. Pedersen SB, Borglum JD, Schmitz O, et al: Abdominal obesity is associated with insulin resistance and reduced glycogen synthetase activity in skeletal muscle. Metabolism 1993; 42: 998-1005.
15. Ko GT, Cockram CS, Chow CC, et al: High prevalence of metabolic syndrome in Hong Kong Chinese - comparison of three diagnostic criteria. Diabetes Res Clin Pract 2005; 69: 160-168.
16. Chuang SY, Chen CH, Chou P: Prevalence of metabolic syndrome in a large health check-up population in Taiwan. J Chin Med Assoc 2004; 67: 611-620.
17. Thomas GN, Ho SY, Janus ED, et al: The US National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005; 67: 251-257.
18. Gu D, Reynolds K, Wu X, et al: Prevalence of the metabolic syndrome and overweight among adults in China. Lancet 2005; 365: 1398-1405.
19. Sun F, Tao QS, Zhan SY: Comparison of five different diagnostic criteria on metabolic syndrome applied during physical check-up programs among population aged 35-74, in Taiwan. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29: 925-929 [in Chinese].
20. Hoang KC, Le TV, Wong ND: The metabolic syndrome in East Asians. J Cardiometab Syndr 2007; 2: 276-282.
21. Meigs JB, Wilson PW, Nathan DM, et al: Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003; 52: 2160-2167.
22. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
23. Ford ES: Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745-2749.
24. Wang W: Main points on Chinese hypertension guidelines. Medicine and Philosophy (Clinical Decision Making Forum Edition) 2006; 27: 9-16 [in Chinese].
25. Weng X, Liu Y, Ma J, et al: An urban-rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public Health Nutr 2007; 10: 131-136.
26. Feng Y, Hong X, Li Z, et al: Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring) 2006; 14: 2089-2098.
27. Lidofsky SD: Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment. Curr Diab Rep 2008; 8: 25-30.
28. Kwaśniewska M, Kaleta D, Dziankowska-Zaborszczyk E, et al: Healthy behaviours, lifestyle patterns and sociodemographic determinants of the metabolic syndrome. Cent Eur J Public Health 2009; 17: 14-19.
29. Wada T, Fukumoto T, Ito K, et al: Of the three classifications of healthy lifestyle habits, which one is the most closely associated with the prevention of metabolic syndrome in Japanese? Intern Med 2009; 48: 647-655.